AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 51 filers reported holding AEVI GENOMIC MEDICINE INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $156,000 | -32.8% | 1,066,587 | -31.2% | 0.00% | – |
| Q3 2019 | $232,000 | +15.4% | 1,549,272 | +23.7% | 0.00% | – |
| Q2 2019 | $201,000 | +50.0% | 1,252,050 | +82.6% | 0.00% | – |
| Q1 2019 | $134,000 | -73.6% | 685,553 | -5.5% | 0.00% | – |
| Q4 2018 | $508,000 | -58.2% | 725,793 | -26.4% | 0.00% | – |
| Q3 2018 | $1,214,000 | +12.7% | 986,590 | +1.7% | 0.00% | – |
| Q2 2018 | $1,077,000 | -43.2% | 970,452 | +2.9% | 0.00% | – |
| Q1 2018 | $1,896,000 | +108.1% | 943,084 | +24.1% | 0.00% | – |
| Q4 2017 | $911,000 | -25.0% | 759,857 | -21.2% | 0.00% | – |
| Q3 2017 | $1,214,000 | -7.5% | 963,829 | -2.3% | 0.00% | – |
| Q2 2017 | $1,312,000 | -43.1% | 986,707 | -20.4% | 0.00% | – |
| Q1 2017 | $2,305,000 | -61.5% | 1,239,425 | +7.2% | 0.00% | – |
| Q4 2016 | $5,987,000 | – | 1,155,752 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 128,000 | $142,000 | 0.10% |
| Baker Brothers Advisors | 4,055,142 | $4,501,000 | 0.03% |
| WEDBUSH SECURITIES INC | 209,524 | $233,000 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,500,000 | $6,105,000 | 0.01% |
| Verity Asset Management, Inc. | 11,500 | $13,000 | 0.01% |
| OneDigital Investment Advisors LLC | 11,437 | $13,000 | 0.00% |
| HYMAN CHARLES D | 15,143 | $17,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 120,619 | $134,000 | 0.00% |
| Legacy Advisors, LLC | 2,450 | $3,000 | 0.00% |
| Kavar Capital Partners, LLC | 1,500 | $2,000 | 0.00% |